首页> 外文期刊>JACC. Cardiovascular imaging. >Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques.
【24h】

Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques.

机译:血管造影对比增强超声成像:从早期动脉粥样硬化到不稳定斑块的识别。

获取原文
获取原文并翻译 | 示例
           

摘要

Proliferation of the adventitial vasa vasorum (VV) is inherently linked with early atherosclerotic plaque development and vulnerability. Recently, direct visualization of arterial VV and intraplaque neovascularization has emerged as a new surrogate marker for the early detection of atherosclerotic disease. This clinical review focuses on contrast-enhanced ultrasound (CEUS) as a noninvasive application for identifying and quantifying carotid and coronary artery VV and intraplaque neovascularization. These novel approaches could potentially impact the clinician's ability to identify individuals with premature cardiovascular disease who are at high risk. Once clinically validated, the uses of CEUS may provide a method to noninvasively monitor therapeutic interventions. In the future, the therapeutic use of CEUS may include ultrasound-directed, site-specific therapies using microbubbles as vehicles for drug and gene delivery systems. The combined applications for diagnosis and therapy provide unique opportunities for clinicians to image and direct therapy for individuals with vulnerable lesions.
机译:外膜血管脉(VV)的扩散与早期动脉粥样硬化斑块的发展和脆弱性有内在联系。最近,直接可视化动脉VV和斑块内新血管形成已成为早期发现动脉粥样硬化疾病的新替代标志。这项临床研究的重点是造影剂超声(CEUS),它是一种非侵入性应用,可用于识别和量化颈动脉和冠状动脉VV和斑块内新血管形成。这些新颖的方法可能会影响临床医生识别高风险的过早心血管疾病患者的能力。一旦经过临床验证,CEUS的使用可能会提供一种无创监测治疗干预措施的方法。将来,CEUS的治疗用途可能包括使用微气泡作为药物和基因传递系统媒介物的超声定向,特定部位治疗。诊断和治疗的组合应用为临床医生提供了独特的机会,可以对具有脆弱病变的个体进行成像和直接治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号